ORIGINAL ARTICLE

Occupational exposure to cytotoxic drugs in two UK oncology wards

E Ziegler¹, H J Mason³, P J Baxter²

¹ Southampton University Hospital Trust, Southampton, UK
² Department of Occupational Health, Addenbrooke's NHS Trust, Cambridge CB2 2QQ, UK
³ Health and Safety Laboratory, Broad Lane, Sheffield S3 7HQ, UK

Correspondence to:
Correspondence to:
Dr H J Mason, Health and Safety Laboratory, Broad Lane, Sheffield S3 7HQ, UK;
howard.mason{at}hsl.gov.uk

Aims: To investigate the potential exposure to cytotoxic drugs of staff on two oncology wards in a large district, UK hospital under normal working conditions.

Methods: Cytotoxic drug exposure was monitored in urine samples, surface wipes, and on disposable gloves by using a number of commonly used marker drugs, namely cyclophosphamide, ifosfamide, methotrexate, and the platino coordinated drugs. Questionnaire data on their work practices, potential exposure, use of protective personal equipment, and relevant training were collected from nursing, domestic, and clerical staff on two oncology wards.

Results: The majority of staff were female with a mean age of 31 years. Roughly half of the staff studied were specifically trained nurses with an average of 3.5 years experience of administering cytotoxic drugs. No cytotoxic drug preparation or reconstitution was carried out on the wards. Disposable gloves, plastic armlets and aprons, but not eye protection, were invariably worn where there was potential exposure to cytotoxics. No cytotoxic drug was detected in any of the staff's urine samples. Isolated disposable latex gloves from nurses administering drugs showed some contamination, as did some surfaces within the wards' sluice rooms, but not in the ward areas where the drugs were stored and checked prior to administration.

Conclusions: The risk management strategies in place, including use of personal protective equipment, staff training, and other organisational measures, have ensured that internal exposure is lower than the detection limits for the current biological monitoring methods. Levels of contamination appear significantly lower than earlier, non-UK published studies where different risk management strategies were in place and, in particular, ward staff may have been involved in some degree of cytotoxic drug reconstitution.

Keywords: antineoplastic agent; biological monitoring; environmental monitoring

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Schierl, R., Bohlandt, A., Nowak, D. (2009). Guidance Values for Surface Monitoring of Antineoplastic Drugs in German Pharmacies. ANN OCCUP HYG 53: 703-711 [Abstract] [Full Text]  
• Korinth, G., Schmid, K., Midasch, O., Boettcher, M. I., Angerer, J., Drexler, H. (2007). Investigations on Permeation of Mitomycin C Through Double Layers of Natural Rubber Gloves. ANN OCCUP HYG 0: mem039v1-mem039 [Abstract] [Full Text]  
• ACAMPORA, A., CASTIGLIA, L., MIRAGLIA, N., PIERI, M., SOAVE, C., LIOTTI, F., SANNOLO, N. (2005). A Case Study: Surface Contamination of Cyclophosphamide due to Working Practices and Cleaning Procedures in Two Italian Hospitals. ANN OCCUP HYG 49: 611-618 [Abstract] [Full Text]  
• MASON, H. J., BLAIR, S., SAMS, C., JONES, K., GARFITT, S. J., CUSCHIERI, M. J., BAXTER, P. J. (2005). Exposure to Antineoplastic Drugs in Two UK Hospital Pharmacy Units. ANN OCCUP HYG 49: 603-610 [Abstract] [Full Text]  
• MASON, H. J., MORTON, J., GARFITT, S. J., IQBAL, S., JONES, K. (2003). Cytotoxic Drug Contamination on the Outside of Vials Delivered to a Hospital Pharmacy. ANN OCCUP HYG 47: 681-685 [Abstract] [Full Text]